Form 4: Xylem Inc. Executive Michael J. McGann Reports Stock Transactions Following Vesting of Performance-Based Stock Units
SEC Form 4
Michael J. McGann, SVP & President Americas & MCS at Xylem Inc., reports acquisition and disposal of common stock related to vesting of performance-based stock units and tax liability coverage.
Summary
- On March 1, 2025, Michael J. McGann, SVP & President Americas & MCS of Xylem Inc., reported transactions involving Xylem's common stock.
- McGann acquired 526 shares at $129.78 each upon vesting of performance-based stock units related to Total Shareholder Return.
- He also acquired 630 shares at $129.78 each upon vesting of performance-based stock units related to ROIC.
- An additional 630 shares were acquired at $129.78 each upon vesting of performance-based stock units related to Revenue.
- 544 shares were disposed of to cover tax liabilities related to the vesting of performance-based stock units.
- 406 shares were disposed of to cover tax liabilities related to the vesting of restricted stock units granted in 2022, 2023 and 2024.
- Following these transactions, McGann beneficially owns 6,541 shares of Xylem Inc. common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The document primarily reports stock transactions related to vesting of stock units, which is a routine part of executive compensation. The vesting suggests the achievement of performance targets, which is mildly positive, but the tax-related disposals are neutral.
Positives
- The vesting of performance-based stock units suggests that the company has met certain performance criteria related to Total Shareholder Return, ROIC, and Revenue.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are often tied to performance-based compensation plans. These transactions provide insights into management's perspective on the company's performance and future prospects.
Stakeholder Impact
- The vesting of performance-based stock units can be seen as a positive signal to shareholders, indicating that the company is achieving its performance goals.
Key Dates
| Date | Description |
|---|---|
| 2016-02-24 | Date of the Amended and Restated Xylem Omnibus Incentive Plan. |
| 2022-03-01 | Grant date of performance-based stock units. |
| 2023-03-01 | Grant date of restricted stock units. |
| 2024-03-01 | Grant date of restricted stock units. |
| 2025-03-01 | Date of stock transactions (acquisition and disposal). |
| 2025-03-04 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.